Obat termolabil menjadi salah satu hal yang perlu diperhatikan dalam penyimpanannya, mengingat stabilitas obat ini sangat dipengaruhi oleh suhu penyimpanan. Pedoman penyimpanan obat yang baik perlu diterapkan untuk memenuhi persyaratan mutu, keamanan, serta khasiat obat dan/ atau bahan obat yang didistribusikan serta dalam rangka keselamatan pasien (patient safety) sesuai dengan rekomendasi industri produsen. Tugas khusus ini diselesaikan menggunakan metode kualitatif dengan studi literatur sebagai sumber untuk memperbaharui buku Panduan Penanganan Obat Termolabil RSCM 2018. Berdasarkan data yang dikumpulkan, didapatkan total 35 nama dagang baru dari golongan antibiotik, antineoplastik, analgesik/ antipiretik, obat untuk saluran cerna, reagen, dan suplemen yang belum masuk ke dalam Buku Panduan Penanganan Obat Termolabil RSCM tahun 2018. Penyimpanan obat termolabil di RSUPN Dr. Cipto Mangunkusumo sudah sesuai dengan data stabilitas penyimpanan dan Peraturan Badan Pengawas Obat dan Makanan Nomor 6 tentang Cara Distribusi Obat yang Baik khususnya pada bab Ketentuan Khusus Produk Rantai Dingin.

---

Thermolabile drugs are one of the things that need to be considered in their storage, considering that the stability of these drugs is strongly influenced by storage temperature. Guidelines for good drug storage need to be implemented to meet the requirements for quality, safety and efficacy of drugs and/or drug substances being distributed as well as for patient safety in accordance with the recommendations of the manufacturer's industry. This special task was completed using a qualitative method with literature studies as a source for updating the RSCM 2018 Handbook for Handling of Thermolabile Drugs. Based on the data collected, a total of 35 new trade names were obtained from the classes of antibiotics, antineoplastic, analgesic/antipyretic, drugs for the gastrointestinal tract, reagents, and supplements that have not been included in the 2018 RSCM Handbook for Handling Thermolabile Medicines. Storage of thermolabile drugs at RSUPN Dr. Cipto Mangunkusumo complies with storage stability data and Drug and Food Control Agency Regulation Number 6 (2020) concerning Good Drug Distribution Methods, especially in the chapter on Special Provisions for Cold Chain Products.